Vis enkel innførsel

dc.contributor.authorBerg, Torill
dc.contributor.authorJensen, Jørgen
dc.date.accessioned2013-04-11T06:58:40Z
dc.date.available2013-04-11T06:58:40Z
dc.date.issued2013-02-28
dc.identifierSeksjon for fysisk prestasjonsevne / Department of Physical Performance
dc.identifier.citationFrontiers i Neuroscience. 2013, 4, 19no_NO
dc.identifier.issn1662-453X
dc.identifier.issn1662-453X
dc.identifier.urihttp://hdl.handle.net/11250/170984
dc.description© 2013 Berg and Jensen. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.no_NO
dc.description.abstractα2-Adrenoceptor-activation lowers central sympathetic output, peripheral, vesicular norepinephrine release, epinephrine secretion, and modulates vascular tension. We previously demonstrated that α2-adrenoceptor-mediated inhibition of basal norepinephrine release was not reflected in plasma unless re-uptake through the norepinephrine transporter (NET) was blocked. Tyramine activates reverse norepinephrine transport through NET. Here we tested the hypothesis that tyramine, by engaging NET in release, also blocks re-uptake, and therefore allows manipulation of pre-junctional α2-adrenoceptors to directly regulate norepinephrine overflow to plasma. We compared in anesthetized spontaneously hypertensive rats (SHRs) and normotensive controls (WKYs), the effect of α2-adrenoreceptor antagonist (L-659,066) and/or agonist (clonidine) on norepinephrine overflow and increase in total peripheral vascular resistance (TPR) evoked by tyramine-infusion (1.26 μmol/min/kg, 15 min) and epinephrine secretion activated by the surgical stress. TPR was computed as blood pressure divided by cardiac output, recorded as ascending aortic flow. Plasma catecholamine concentrations after tyramine were higher in SHRs than WKYs. Pre-treatment with L-659,066 increased the catecholamine concentrations in WKYs, but only if combined with clonidine in SHRs. Clonidine alone reduced tyramine-induced norepinephrine overflow in SHRs, and epinephrine in both strains. Tyramine-induced increase in TPR was not different after clonidine, eliminated after L-659,066 and L-659,066 + clonidine in WKYs, but only after L-659,066 + clonidine in SHRs. We conclude that tyramine-infusion does allow presynaptic regulation of vesicular release to be accurately assessed by measuring differences in plasma norepinephrine concentration. Our results indicate that presynaptic α2-adrenoceptor regulation of norepinephrine release from nerve vesicles and epinephrine secretion is dysfunctional in SHRs, but can be restored by clonidine.no_NO
dc.language.isoengno_NO
dc.publisherFrontiers Mediano_NO
dc.subjectα2-adrenoceptorsno_NO
dc.subjecthypertensionno_NO
dc.subjectsympathetic nervous systemno_NO
dc.subjectnorepinephrineno_NO
dc.subjectepinephrineno_NO
dc.subjectrelease controlno_NO
dc.subjecttotal peripheral vascular resistanceno_NO
dc.titleTyramine reveals failing α2-adrenoceptor control of catecholamine release and total peripheral vascular resistance in hypertensive ratsno_NO
dc.typeJournal articleno_NO
dc.typePeer reviewedno_NO
dc.subject.nsiVDP::Medical disciplines: 700::Basic medical, dental and veterinary science disciplines: 710no_NO
dc.source.journalFrontiers in Neuroscience
dc.identifier.doi10.3389/fneur.2013.00019


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel